会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 114. 发明申请
    • Methods for identifying and administering agents that bias the immune response via dendritic cells
    • 用于鉴定和施用通过树突状细胞偏置免疫应答的药剂的方法
    • US20040259790A1
    • 2004-12-23
    • US10769635
    • 2004-01-30
    • Bali PulendranSudhanshu AgrawalStephanie Maree Dillon
    • A61K038/17
    • C12N5/0639A61K2035/122A61K2039/57C12N5/0636C12N2501/052C12N2501/998
    • The invention provides a method of regulating a Th2 immune response which comprises contacting a cell with an amount of a molecule effective to modulate an ERK null pathway and/or a c-FOS pathway in the cell so as a to regulate the TH2 immune response, which molecule is any of (a) an agonist of a TLR2 or a TLR2 variant; (b) an agonist of an intracellular pathway that is initiated by activation of a TLR2; (c) an agonist of an intracellular pathway that is initiated by activation of a receptor activated by SEA; (d) an antagonist of an intracellular pathway that opposes TLR2 signaling or activation; (e) an agonist of an ERK null pathway; (f) an antagonist of a p38 pathway; (g) an antagonist of a JNK null pathway; or (h) an agonist of the c-FOS pathway, or a molecule that induces c-Fos gene expression, c-Fos messenger RNA stability, c-Fos protein induction, c-Fos protein stability, or c-Fos protein phosphorylation.
    • 本发明提供了一种调节Th2免疫应答的方法,其包括使细胞与一定量的有效调节细胞中ERK 1/2途径和/或c-FOS途径的分子接触,以调节TH2免疫应答, 该分子是(a)TLR2或TLR2变体的激动剂中的任一种; (b)通过激活TLR2引发的细胞内途径的激动剂; (c)由SEA激活的受体的活化引发的细胞内途径的激动剂; (d)抗TLR2信号传导或激活的细胞内途径的拮抗剂; (e)ERK 1/2途径的激动剂; (f)p38途径的拮抗剂; (g)JNK 1/2途径的拮抗剂; 或(h)c-FOS途径的激动剂,或诱导c-Fos基因表达的分子,c-Fos信使RNA稳定性,c-Fos蛋白诱导,c-Fos蛋白稳定性或c-Fos蛋白磷酸化。